Orchestra BioMed Holdings, Inc. (OBIO)

Orchestra BioMed Holdings Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	28.37	34.69	22.26	30.56	19.78	1.75
Short-Term Investments	66.03	71.82	44.55	57.04	64	-
Cash & Short-Term Investments	94.4	106.51	66.81	87.6	83.79	1.75
Cash Growth	89.24%	59.42%	-23.73%	4.55%	4675.54%	-13.44%
Accounts Receivable	0.08	0.1	0.09	0.1	0.1	-
Inventory	0.28	0.31	0.17	0.15	0.28	-
Other Current Assets	1.45	0.99	2.09	1.27	0.53	0.05
Total Current Assets	96.21	107.91	69.17	89.11	84.69	1.8
Net Property, Plant & Equipment	3.19	3.21	3.49	2.83	3.68	-
Long-Term Investments	-	2.5	2.5	2.5	2.5	160.02
Other Long-Term Assets	1.26	1.24	1.02	0.77	4.71	-
Total Assets	100.66	114.86	76.17	95.21	95.57	161.82

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	6.31	6.1	5.13	2.9	3.97	0
Accrued Expenses	6.59	9.89	6.08	5.15	5.38	0.16
Current Portion of Leases	0.79	0.75	0.55	0.65	0.7	-
Unearned Revenue	-	-	4.44	2.51	6.44	-
Other Current Liabilities	-	-	-	-	2.09	-
Total Current Liabilities	13.69	16.74	16.21	11.21	18.57	0.17
Long-Term Debt	32.12	30.75	14.29	-	9.49	-
Long-Term Leases	0.73	0.94	1.69	1.04	1.68	-
Other Long-Term Liabilities	3.15	3.06	11.03	14.92	13.3	5.6
Total Long-Term Liabilities	36	34.74	27.01	15.96	24.47	5.6
Total Liabilities	49.69	51.48	43.22	27.17	43.04	5.77

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Preferred Stock	9.77	9.81	-	-	-	-
Common Stock	0.01	0.01	0	0	0	0
Additional Paid-in Capital	424.5	416.08	342.78	316.9	252.27	-
Accumulated Other Comprehensive Income	-0.04	0.06	0.05	-0.01	-0.01	-
Retained Earnings	-383.27	-362.58	-309.88	-248.85	-199.73	-3.94
Total Common Shareholders' Equity	50.97	63.38	32.96	68.04	52.53	-3.94
Minority Interest	-	-	-	-	-	160
Shareholders' Equity	50.97	63.38	32.96	68.04	52.53	156.06
Total Liabilities & Equity	100.66	114.86	76.17	95.21	95.57	161.82

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	33.64	32.44	16.53	1.69	11.87	0
Net Cash (Debt)	60.77	74.08	50.28	85.91	71.92	1.75
Net Cash Growth	81.71%	47.32%	-41.47%	19.46%	3998.98%	-13.44%
Net Cash Per Share	1.13	1.55	1.37	2.59	4.80	0.20
Book Value	50.97	63.38	32.96	68.04	52.53	-3.94
Book Value Per Share	0.95	1.33	0.90	2.05	3.50	-0.45
Tangible Book Value	50.97	63.38	32.96	68.04	52.53	-3.94
Tangible Book Value Per Share	0.95	1.33	0.90	2.05	3.50	-0.45

SEC Filings: 10-K · 10-Q

Data Source: Fiscal.ai Last updated: May 12, 2026

Financial data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 4, 2026

Data Sources Report a data error